These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Digestive hemorrhage caused by excessive hypocoagulation induced by interaction of piroxicam and a vitamin K antagonist]. Desprez D; Blanc P; Larrey D; Michel H Gastroenterol Clin Biol; 1992; 16(11):906-7. PubMed ID: 1483568 [No Abstract] [Full Text] [Related]
6. [Hypocoagulation caused by thiabendazole-acenocoumarol interaction]. Henri P; Mosquet B; Hurault de Ligny B; Lacotte J; Cardinau E; Moulin M; Ryckelinck JP Therapie; 1993; 48(5):500-1. PubMed ID: 8146845 [No Abstract] [Full Text] [Related]
7. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial. Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676 [TBL] [Abstract][Full Text] [Related]
9. [Potentialization of the anticoagulant action of antivitamin K by thienylic acid]. Grand A; Drouin B; Arche GJ Nouv Presse Med; 1977 Sep; 6(30):2691. PubMed ID: 302935 [No Abstract] [Full Text] [Related]
10. [Potentiation of the effects of acenocoumarol by miconazole]. Ponge T; Barrier J; Spreux A; Guillou B; Larousse C; Grolleau JY Therapie; 1982; 37(2):221-2. PubMed ID: 7112491 [No Abstract] [Full Text] [Related]
11. Enhanced anticoagulant effect of coumarin derivatives induced by doxycycline coadministration. Caraco Y; Rubinow A Ann Pharmacother; 1992 Sep; 26(9):1084-6. PubMed ID: 1421670 [TBL] [Abstract][Full Text] [Related]
12. CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring? Schalekamp T; Boink GJ; Visser LE; Stricker BH; de Boer A; Klungel OH Clin Pharmacol Ther; 2006 Jun; 79(6):511-20. PubMed ID: 16765138 [No Abstract] [Full Text] [Related]
13. [The potentiation of the anticoagulant effect of acenocoumarol by cefonicid]. Puente García M; Bécares Martínez FJ; Merlo Arroyo J; García Sánchez G; García Díaz B; Cervero Jiménez M Rev Clin Esp; 1999 Sep; 199(9):620-1. PubMed ID: 10568163 [No Abstract] [Full Text] [Related]
14. [Hemorrhagic incidents during prolonged ambulatory treatment with acenocoumarol]. Reverter JC; Tàssies D; Maragall S; Monteagudo J; Escolar G; Ordinas A Med Clin (Barc); 1995 Jun; 105(4):127-30. PubMed ID: 7623503 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation. Tàssies D; Freire C; Pijoan J; Maragall S; Monteagudo J; Ordinas A; Reverter JC Haematologica; 2002 Nov; 87(11):1185-91. PubMed ID: 12414349 [TBL] [Abstract][Full Text] [Related]
18. Possible interaction between topical terbinafine and acenocoumarol. Morales-Molina JA; Arrebola MA; Robles PA; Mangana JC Ann Pharmacother; 2009 Nov; 43(11):1911-2. PubMed ID: 19843835 [No Abstract] [Full Text] [Related]
19. Bleeding complication during coumarin therapy due to amiodarone and azithromycin. Bharat V; Mohanty B J Assoc Physicians India; 2000 Jul; 48(7):746-7. PubMed ID: 11273517 [TBL] [Abstract][Full Text] [Related]
20. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases]. Katona A; Márk L Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]